Tempest Therapeutics (TPST)
(Delayed Data from NSDQ)
$2.23 USD
+0.06 (2.76%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $2.22 -0.01 (-0.45%) 4:26 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/08/2024
Time: -- |
6/2024 | $-0.47 | -19.15% |
Earnings Summary
For their last quarter, Tempest Therapeutics (TPST) reported earnings of -$0.36 per share, beating the Zacks Consensus Estimate of $-0.44 per share. This reflects a positive earnings surprise of 18.18%. Look out for TPST's next earnings release expected on August 08, 2024. For the next earning release, we expect the company to report earnings of -$0.47 per share, reflecting a year-over-year increase of 12.96%.
Earnings History
Price & Consensus
Zacks News for TPST
All You Need to Know About Tempest Therapeutics, Inc. (TPST) Rating Upgrade to Buy
TPST: What are Zacks experts saying now?
Zacks Private Portfolio Services